0001493152-24-011836.txt : 20240328 0001493152-24-011836.hdr.sgml : 20240328 20240328210008 ACCESSION NUMBER: 0001493152-24-011836 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240326 FILED AS OF DATE: 20240328 DATE AS OF CHANGE: 20240328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alder Matthias CENTRAL INDEX KEY: 0001370820 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40237 FILM NUMBER: 24801697 MAIL ADDRESS: STREET 1: C/O MICROMET, INC. STREET 2: 6707 DEMOCRACY BLVD., STE. 505 CITY: BETHESDA STATE: MD ZIP: 28017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gain Therapeutics, Inc. CENTRAL INDEX KEY: 0001819411 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 851726310 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4800 HAMPDEN LANE STREET 2: SUITE 200 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: (301) 500-1556 MAIL ADDRESS: STREET 1: 4800 HAMPDEN LANE STREET 2: SUITE 200 CITY: BETHESDA STATE: MD ZIP: 20814 4 1 ownership.xml X0508 4 2024-03-26 0 0001819411 Gain Therapeutics, Inc. GANX 0001370820 Alder Matthias C/O GAIN THERAPEUTICS, INC. 4800 MONTGOMERY LANE, SUITE 220 BETHESDA MD 20814 1 1 0 0 Chief Executive Officer 0 Common Stock 2024-03-26 4 M 0 18750 A 25763 D Common Stock 2024-03-26 4 M 0 825 A 26588 D Common Stock 2024-03-26 4 M 0 637 A 27225 D Common Stock 2024-03-26 4 F 0 6085 4.06 D 21140 D Restricted Stock Units 2024-03-26 4 M 0 18750 0.00 D Common Stock 18750 56250 D Restricted Stock Units 2024-03-26 4 M 0 825 0.00 D Common Stock 249 8250 D Restricted Stock Units 2024-03-26 4 M 0 637 0.00 D Common Stock 192 6376 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. The RSUs vested 25% on the one-year anniversary of the grant date and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date. The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date. /s/ Matthias Alder 2024-03-28